| Price and Chart delayed at least 15 mintues. |
|
Price
$ 45.90
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
45.90
|
Volume
NA
|
|
Market Value
42 bil
|
P/E Ratio
20.8
|
|
Bid
44.44
|
EPS
2.21
|
|
Ask
46.20
|
Dividend
0.00
|
|
High
0.00
|
Yield
0.0
|
|
Low
0.00
|
Shares Out
906 mil
|
|
52wk High
57.63
|
52wk Low
35.60
|
|
Industry: Biotechnology
|
|
Sector: Healthcare
|
GILD Profile
A biopharmaceutical company which discovers, develops and commercializes therapeutics in areas of unmet medical need.
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
Phone: (650) 574-3000
Fax: (650) 578-9264
Web Site: www.gilead.com
GILD Wires Headlines
|
|
| 07.03.09 |
|
UPDATE 1-Hong Kong finds 1st case of Tamiflu-resistant H1N1
|
|
| 07.02.09 |
|
Final Glance: Biotechnology companies
|
|
| 07.02.09 |
|
UPDATE 2-Japan finds first case of H1N1 resistant to Tamiflu
|
|
| 07.02.09 |
|
Midday Glance: Biotechnology companies
|
|
| 07.02.09 |
|
Early Glance: Biotechnology companies
|
More GILD From Wires Headlines >
Forbes.com on GILD RSS
No news found in the past 30 days.
Investopedia on GILD
|